MOODY ALDRICH PARTNERS LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 295 filers reported holding HAEMONETICS CORP in Q3 2018. The put-call ratio across all filers is 1.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
MOODY ALDRICH PARTNERS LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2020$2,193,000
-13.1%
22,001
+0.1%
0.66%
+27.6%
Q4 2019$2,525,000
-8.1%
21,973
+0.9%
0.52%
-29.0%
Q3 2019$2,747,000
+4.0%
21,776
-0.8%
0.73%
+8.3%
Q2 2019$2,642,000
+0.9%
21,957
-26.6%
0.68%
-8.2%
Q1 2019$2,618,000
-11.2%
29,926
+1.5%
0.74%
-24.1%
Q4 2018$2,949,000
-6.1%
29,475
+7.5%
0.97%
+7.0%
Q3 2018$3,142,000
+51.9%
27,421
+18.9%
0.90%
+23.0%
Q2 2018$2,069,00023,0660.74%
Other shareholders
HAEMONETICS CORP shareholders Q3 2018
NameSharesValueWeighting ↓
Nitorum Capital, L.P. 413,122$16,608,0004.78%
Altalis Capital Management LLC 88,055$3,540,0003.97%
RUTABAGA CAPITAL MANAGEMENT LLC/MA 513,619$20,647,0003.54%
Black Creek Investment Management Inc. 1,118,613$44,968,0003.46%
HealthCor Management, L.P. 1,150,000$46,230,0002.61%
Van Berkom & Associates Inc. 1,136,971$45,706,0001.83%
AMERICAN CAPITAL MANAGEMENT INC 567,896$22,829,0001.77%
FULLER & THALER ASSET MANAGEMENT, INC. 2,062,539$82,914,0001.25%
Legato Capital Management LLC 1,336$53,707,0000.97%
HEARTLAND ADVISORS INC 351,314$14,123,0000.78%
View complete list of HAEMONETICS CORP shareholders